Back to Search Start Over

Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma

Authors :
Renata Ferrarotto
Diana Bell
Maria Laura Rubin
Adel K. El-Naggar
Bita Esmaeli
Jing Ning
Steven J. Frank
James Matthew Debnam
Joshua Ford
Source :
British Journal of Ophthalmology. 105:768-774
Publication Year :
2020
Publisher :
BMJ, 2020.

Abstract

Background/aimsTo identify prognostic factors for local recurrence, distant metastasis and disease-specific survival (DSS) for lacrimal gland carcinoma.MethodsAll consecutive patients with lacrimal gland carcinoma treated from January 1998 through December 2018 were included. Log-rank tests and univariate Cox proportional hazards regression models were used to study risk factors and survival.ResultsOverall, 55 patients were included in this study, and 5 patients were excluded from the survival analysis. Median age was 46 years (range: 10–76). 43 patients (78%) had adenoid cystic carcinoma (ACC). 31 patients (56%) had T2 disease at presentation. 28 patients (51%) underwent orbital exenteration with or without adjuvant radiotherapy or chemoradiation, 26 (47%) underwent eye-sparing surgery with or without adjuvant radiotherapy or chemoradiation, and 1 received palliative chemoradiation. 11 patients (22%) experienced local recurrence; 14 (29%) experienced distant metastasis. Five- and 10-year local-recurrence-free survival rates were 0.71 (95% CI 0.58 to 0.88), and 5- and 10-year distant-metastasis-free survival rates were 0.67 (95% CI 0.53 to 0.85) and 0.49 (95% CI 0.30 to 0.81), respectively. There was no significant difference in risks of local recurrence, distant metastasis or DSS between ACC patients who had orbital exenteration and those who had eye-sparing surgery. Perineural invasion was negatively associated with local-recurrence-free survival (p=0.02). Among patients with ACC, basaloid/solid histologic type was associated with significantly worse DSS than non-basaloid/solid histologic type (pConclusionsFor lacrimal gland carcinoma, orbital exenteration with adjuvant therapy and eye-sparing surgery with adjuvant therapy are associated with similar recurrence outcomes. Eye-sparing surgery is associated with better DSS. Perineural invasion is a risk factor for local recurrence. ACC with basaloid/solid subtype correlates with worse DSS.

Details

ISSN :
14682079 and 00071161
Volume :
105
Database :
OpenAIRE
Journal :
British Journal of Ophthalmology
Accession number :
edsair.doi.dedup.....6db6df6f14d5db929214fa6d1f97c265
Full Text :
https://doi.org/10.1136/bjophthalmol-2020-316142